Why the study?
Conflicting reports exist regarding outcomes in women presenting with ACS, prompting investigation into sex-specific differences in 30-day mortality in patients with ACS and acute HF at presentation.
Does female sex affect 30-day mortality and the likelihood of presenting with acute heart failure in patients with acute coronary syndromes?
Does female sex affect 30-day mortality and the likelihood of presenting with acute heart failure in patients with acute coronary syndromes?
Women presenting with ACS have higher mortality than men, which may be partly explained by a higher likelihood of presenting with acute heart failure, particularly in the setting of STEMI.
Acute HF markedly raises ACS mortality risk; extends sex-disparity observations in STEMI but remains hypothesis-generating and should not yet change practice.
Background: There have been conflicting reports regarding outcomes in women presenting with an acute coronary syndrome (ACS). Objectives: The objective of the study was to examine sex-specific differences in 30-day mortality in patients with ACS and acute heart failure (HF) at the time of presentation. Methods: This was a retrospective study of patients included in the International Survey of Acute Coronary Syndromes-ARCHIVES (ISACS-ARCHIVES; NCT04008173). Acute HF was defined as Killip classes ≥2. Participants were stratified according to ACS presentation: ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation ACS (NSTE-ACS). Differences in 30-day mortality and acute HF presentation at admission between sexes were examined using inverse propensity weighting based on the propensity score. Estimates were compared by test of interaction on the log scale. The presence of acute HF increased the risk of mortality for both sexes (odds ratio: 6.60; 95% CI: 6.25-6.98). Conclusions: In patients presenting with ACS, mortality is higher in women. The presence of acute HF at hospital presentation increases the risk of mortality in both sexes. Women with STEMI are more likely to present with acute HF and this may, in part, explain sex differences in mortality. These findings may be helpful to improve sex-specific personalized risk stratification.
No takes yet. Share an insight, caveat, or question.
Cenko et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: